Safety and immunogenicity of S-Trimer (SCB-2019), a protein subunit vaccine candidate for COVID-19 in healthy adults: a phase 1, randomised, double-blind, placebo-controlled trial

Peter Richmond, Lara Hatchuel, Min Dong, +8

The Lancet

S-Trimer, a COVID-19 subunit vaccine candidate, induces protective immunity in nonhuman primates

Joshua G. Liang, Danmei Su, Tian‐Zhang Song, +22

Nature Communications

Efficacy of the adjuvanted subunit protein COVID-19 vaccine, SCB-2019: a phase 2 and 3 multicentre, double-blind, randomised, placebo-controlled trial

Lulu Bravo, Igor Smolenov, Htay Htay Han, +44

The Lancet

VaccinologyVaccine SafetyVaccinationVaccine DevelopmentImmunology +7

Improvement of Pharmacokinetic Profile of TRAIL via Trimer-Tag Enhances its Antitumor Activity in vivo

Haipeng Liu, Danmei Su, Jinlong Zhang, +11

Scientific Reports

S-Trimer, a COVID-19 subunit vaccine candidate, induces protective immunity in nonhuman primates

Joshua G. Liang, Danmei Su, Tian‐Zhang Song, +22

VaccinationVaccine DevelopmentMedicineVaccine TargetImmunology +12

A Broad Blockade of Signaling from the IL-20 Family of Cytokines Potently Attenuates Collagen-Induced Arthritis

Xinyu Liu, Hong Zhou, Xueqin Huang, +10

The Journal of Immunology

ImmunologyImmune RegulationInnate ImmunityDermatologyImmune System +22

Impact of previous exposure to SARS-CoV-2 and of S-Trimer (SCB-2019) COVID-19 vaccination on the risk of reinfection: a randomised, double-blinded, placebo-controlled, phase 2 and 3 trial

Igor Smolenov, Htay Htay Han, Ping Li, +9

The Lancet Infectious Diseases

VaccinationVaccine SafetyPrevious ExposureCovid-19 PandemicVaccine Efficacy +6

Broad neutralization against SARS-CoV-2 variants induced by a modified B.1.351 protein-based COVID-19 vaccine candidate

Danmei Su, Xinglin Li, Cui He, +18

ImmunologyPrototype S-trimer VaccineImmunodominancePrototype S-trimerBroad-spectrum Vaccines +14

Persistence of the Immune Responses and Cross-Neutralizing Activity With Variants of Concern Following 2 Doses of Adjuvanted SCB-2019 Coronavirus Disease 2019 Vaccine

Peter Richmond, Lara Hatchuel, Filippo Pacciarini, +7

The Journal of Infectious Diseases

Immunogenicity of SCB-2019 Coronavirus Disease 2019 Vaccine Compared With 4 Approved Vaccines

Donna M. Ambrosino, Htay Htay Han, Branda Hu, +5

The Journal of Infectious Diseases